Scientific and Regulatory Due Diligence

• Evaluation of biotechnology projects, covering all phases of product development including: CMC, pre-clinical, clinical and regulatory interactions
• Evaluation of biotechnology companies, covering review of business plans, scientific, regulatory, and CMC evaluation
• Assessment of patentability
• Identification of project’s /company’s assets as well as weaknesses and limitations